4.1 Anti Epileptic Drugs Flashcards
Define epilepsy
Recurrent tendency to spontaneous intermittent abnormal electrical activity in brain leading to seizure
Seizures may be with or without loss of __________, and with or without __________
A Seizure in the motor cortex area will cause __________
consciousnes, convulsions, convulsions
What 2 things must we be aware of when prescribing Anti Epileptic Drugs (AEDs)
1) ADRs - Common, some serious
2) DDIs - Some positive combined with other AEDs but often negative PK interactions
Give a medico-social consequence of misdiagnosis of Epilepsy
ban on driving a car (+ other social ,financial, medical implications)
What causes Epilepsy? (4)
(NEIL)
Increase in Cerebral Neurone Excitability by :
- Spread of Neuronal Hyperactivity
- Increased Excitation
- Decreased Inhibition
- Loss of Homeostatic Control
What are the TWO main types of Epilepsy?
FOCAL seizures (partial) – affect one (unilateral) hemisphere
GENERALISED seizures – affect both (bilateral) hemispheres
What is Status Epilepticus and how does it differ from other seizures?
Most seizures are short lived (up to 5 mins) BUT Status Epilepticus is prolonged or repeated frequently WITHOUT recovery interval
Medical Emergency!
What are the major risks if Status Epilepticus is not treated?
1) varying degrees of brain dysfunction/damage ➞ by hypoxic encephalopathy
2) death ➞ sudden unexpected death in epilepsy (SUDEP)
Give 4 dangers of severe Epilepsy (not incl brain damage or SUDEP)
- Physical injury relating to fall /crash
- Hypoxia – respiratory muscles in spasm
- Cognitive impairment
- Serious psychiatric disease
- Significant adverse reactions to medication
- Stigma / Loss of livelihood / life changing event
What are the 2 main therapeutic targets for AEDs
1) Voltage Gated Sodium Channel Blockers
2) Enhancing GABA Mediated Inhibition
Explain the mechanism of VGSC hyperactivity in epilepsy
1) local loss of membrane potential homeostasis starts at focal point
2) small number of neurones form a generator site and heavily depolarise
3) hyperactivity spreads via synaptic transmission to other neurones
What is the purpose of VGSC blockers?
VGSC Blockers reduce probability of high abnormal spiking activity so neurons can only fire at a constant rate.
Explain the MoA of VGSC blockers
1) the VGSC blockers enters the chanel and gains access to binding site during depolarisation (when they are open).
2) the blocker stablises this channel as it enters its refractory peroid which prolongs its inactivation state.
3) by increasing the relative refractory period of the chanels it brings the firing rate back to normal.
4) once neurone membrane potential returns back to normal the VGSC Blocker detaches from binding site.
Give 2 common examples of a VGSC blocker
Carbamazepine and Phenytoin
(both prolong VGSC inactivation state)
Carbamazepine is well absorbed (75% protein bound) and exhibits _______ PK.
Its Initial t1/2 is _____ hrs BUT reduces to a t1/2 of _____hrs.
Linear, 30, 15,
Why does t1/2 of Carbamazapine reduce after repeated use?
Carbamazipine is a strong inducer of CYP450 (3A4).This particular isoform of CYPs is actually the one which metabolises carbamazipine itself, hence this drug activates its own phase 1 metabolism. The effect of this is a reduction in its t1/2 to 15hrs after repeated use.
How does the change in t/12 of carabamazipine over time affect the dosage we prescribe to our patients?
Initially start on lower dosage (100-200mg 1-2 per day)
With continued use dose must be increased in steps of around 100-200mg in 2 weeks (800mg-1.2g divided doses throughout day)
Give 2 epilepsy types treated with Carbamazepine
1) Generalised Tonic-Clonic
2) Partial - All
(Not Absence Seizures)
What are some common symptoms of ADRs experienced with carbamazipine?
Wide ranging Type As: affects on the CNS such as –
dizziness, drowsy, ataxia, motor disturbance, numbness & tingling
Give 4 other systemic ADRs that may be experienced with carbamazipine
- GI - upset vomiting
- CV – can cause variation in BP
- Hypersensitivity (Rashes)
- Hyponatraemia
Rarely: Severe bone marrow depression – neutropenia
What is a major contraindication for carbamazipine?
AV conduction problems
As carbamazipine is a CYP450 inducer, it can also increase metabolism of other drugs which decreases their effectivness
Give 4 examples
1) Phenytoin (AED) ➞ also effects its PK/binding due to ↑ conc of CBZ in plasma
2) Warfarin
3) Systemic Corticosteroids
4) Oral contraceptives
What is Stevens-Johnson syndrome (SJS)?
A rare but serious disorder of hypersensitivity caused by an ADR (unpredictable) or sometimes by an infection
It begins with flu-like symptoms, followed by a red or purple rash that spreads and forms blisters. It affects the skin, mucous membrane, genitals and eyes.
Medical emergency! requires treatment in ITU or burns unit
Give a drug class which interferes with the action of Carbamazepine (+ examples)
Antidepressants - SSRIs MAOIs TCAs and TCA
Give 2 things we must always do for drug monitoring of carbamazipine
1) Monitor dosing to effect and adjust dosing as t1/2 decreases
2) Always check BNF with any other drugs given
Phenytoin is well absorbed but 90% is bound in plasma, what is the implication of this on DDIs?
Give 2 examples
Competitive protein binding can increase levels of free phenytoin in plasma which exacerbates Non-Linear PKs
Valproate (AED) and NSAIDs displace bound phenytoin, increasing plasma levels of the free drug
Because Phenytoin shows non-linear kinetics and large intrasubject variability (for dose required to remain within theraputic window), small increases in plasma conc of free drug will have serious effects
Phenytoin is a CYP450 inducers, specifcally isoform ____
3A4
What is the effect of Phenytoin on CYPP450 and how does this differ from carbamazipine
Both induce the CYP3A4 but, phenytoin is metabolised by CYP2C9 and CYP2C19 and so does NOT increases its own metabolism
Why does Carbamazipine increase metabolism of Phenytoin?
because in additon to increasing its own metabolism by inducing CYP3A4 it also induces CYP2C9 which is a metaboliser of Phenytoin
Why can we not calculate t1/2 for phenytoin?
What does this mean for dosing?
Because at theraputic concs it shows NON-LINEAR kinetics and variable t1/2 = 6-24 hrs
There is also big differences with intra-subject variability and hence there is large variability in dose required to get to therapeutic levels